Study register · detail
Unclear
GRADE
Moderate
32 citations
Samplek = 52 Studien
n = 16 Pat.
n = 16 Pat.
Durationunclear
EndpointPsychiatric comorbidities
Blindingunklar
DesignSystematic Review
Key finding
Systematic review describes high comorbidity rates between cannabis use and psychiatric disorders in Indian studies, without measuring a specific intervention effect.
Summary
Systematic review of Indian studies on comorbid cannabis use and psychiatric disorders; k=52 included articles. n=16 studies described acute psychotic episodes with predominantly positive symptoms following cannabis use; n=6 studies observed increased prevalence of all psychiatric disorders due to cannabis; n=14 studies reported high substance use rates in psychiatric patients.
P
PopulationIndian patients with cannabis use disorders and psychiatric comorbidities; 52 included studies
I
InterventionCannabis use disorders (various forms and patterns of exposure)
O
OutcomeHigh co-prevalence of psychotic disorders (mainly acute episodes with positive symptomatology); increased prevalence of all psychiatric disorders as well as high rates of substance use in patients with psychiatric illnesses; cognitive impairments described in seven studies
Confidence in the evidence
Moderate
The third of four GRADE levels, the effect estimate is probably reliable.
Downgraded for
Imprecision
Quality profile
Sample size
★★★★★
Blinding
—
Effect size
—
Citations / year
★★★★★
Authors
Share
Abstract
Background & Objectives: Cannabis is a widely used illicit drug and its use is often associated with co-occurring psychiatric disorders. This systematic review was aimed to provide information on the published Indian studies on co-occurring cannabis use disorders and psychiatric disorders.
Methods: An electronic search of available Indian literature using relevant search terms was carried out in May 2015 and 52 articles in English language published from India were included in the current review.
Results: Studies on cannabis and associated psychotic disorders (n=16) chiefly described acute episodes with predominant positive symptoms, following cannabis use. Some studies (n=6) observed an overall increased prevalence of all psychiatric disorders and symptoms owing to cannabis use, while others (n=14) elaborated on high rates of substance use in those with psychiatric disorders. The effect of cannabis use on cognitive function was the focus of some of the Indian studies (n=7). All these studies barring one had all male subjects, and a single study described the service delivery model for those with dual diagnosis disorders in India. Most of the research used cross-sectional observational design and focussed on treatment-seeking population.
Interpretation & Conclusions: A review of Indian literature on cannabis use and its association with psychiatric disorders indicates a high co-prevalence of psychotic disorders, especially in vulnerable individuals as well as high rates of co-occurrence of other psychiatric comorbidities. However, there is limited focus on exploring the aetiological association between cannabis use and psychiatric disorders; understanding the neurobiology of this association and management-related issues.
The impediment to action advances action.